Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O
Open Access
- 1 April 2001
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (4), 1378-1384
- https://doi.org/10.1128/jcm.39.4.1378-1384.2001
Abstract
Because human immunodeficiency virus type 1 (HIV-1) subtypes and circulating recombinant forms (CRFs) are spreading rapidly worldwide and are becoming less confined to a geographical area, RNA assays that can detect and quantify all HIV-1 isolates reliably are in demand. We have developed a fast, real-time monitored RNA assay based on an isothermal nucleic acid sequence-based amplification technology that amplifies a part of the long terminal repeat region of the HIV-1 genome. Real-time detection was possible due to the addition of molecular beacons to the amplification reaction that was monitored in a fluorimeter with a thermostat. The lower level of detection of the assay was 10 HIV-1 RNA molecules per reaction, and the lower level of quantification was 100 copies of HIV-1 RNA with a dynamic range of linear quantification between 102 and 107 RNA molecules. All HIV-1 groups, subtypes, and CRFs could be detected and quantified with equal efficiency, including the group N isolate YBF30 and the group O isolate ANT70. To test the clinical utility of the assay, a series of 62 serum samples containing viruses that encompassed subtypes A through G and CRFs AE and AG of HIV-1 group M were analyzed, and these results were compared to the results of a commercially available assay. This comparison showed that the quantification results correlated highly (R 2 = 0.735) for those subtypes that could be well quantified by both assays (subtypes B, C, D, and F), whereas improved quantification was obtained for subtypes A and G and CRFs AE and AG. A retrospective study with six individuals infected with either a subtype A, B, C, or D or an AG isolate of HIV-1 group M, who were treated with highly active antiretroviral therapy, revealed that the assay was well suited to the monitoring of therapy effects. In conclusion, the newly developed real-time monitored HIV-1 assay is a fast and sensitive assay with a large dynamic range of quantification and is suitable for quantification of most if not all subtypes and groups of HIV-1.Keywords
This publication has 38 references indexed in Scilit:
- Natural Residues versus Antiretroviral Drug-Selected Mutations in HIV Type 1 Group O Reverse Transcriptase and Protease Related to Virological Drug Failurein VivoAIDS Research and Human Retroviruses, 2000
- Subtype-Specific Sequence Variation of the HIV Type 1 Long Terminal Repeat and Primer-Binding SiteAIDS Research and Human Retroviruses, 2000
- AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and functionAIDS, 1997
- Quantification of HIV-1 RNA in Plasma: Comparable Results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor TestJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 1996
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplificationAIDS, 1993
- Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification ReactionsNature Biotechnology, 1993